Streetbeat News

Stock Prices

TSLA

Tesla Inc. (NASDAQ:TSLA) aims to produce 2.77 million vehicles by 2025, a 50% increase from 2023, including new affordable models. Analyst Gary Black suggests the market underestimates Tesla's expansion into the $30,000 segment. Tesla's current capacity is 2.35 million units, with a potential maximum of 3 million. Despite recent earnings scrutiny, Tesla's resilience is noted.

Portfolio Pulse from Benzinga Neuro

July 29, 2024 | 3:36 am

ETHUSD

MATICUSD

Mark Cuban has expressed his willingness to bet on whether former President Donald Trump will exhibit a 'belly laugh' before the upcoming election on the Ethereum-based prediction market, Polymarket. This bet, while seemingly lighthearted, highlights the growing popularity of Polymarket, which operates on the Ethereum Layer-2 chain Polygon.

Portfolio Pulse from Aniket Verma

July 29, 2024 | 3:24 am

AAPL

MSFT

Leading cryptocurrencies like Bitcoin and Ethereum held their gains as Donald Trump made pro-crypto promises. Bitcoin nearly touched $69,000, and Ethereum retraced to $3,270. Futures Open Interest for both increased, signaling a potential upside breakout. Stock market futures also edged higher, with Microsoft and Apple set to report earnings. The Federal Reserve will hold an FOMC meeting this week.

Portfolio Pulse from Aniket Verma

July 29, 2024 | 2:30 am

BTCUSD

Former President Donald Trump, speaking at the Bitcoin 2024 conference, promised that Bitcoin would 'skyrocket like never before' if he returns to the White House. He also pledged to fire SEC Chair Gary Gensler on his first day in office, which has generated significant excitement in the cryptocurrency community.

Portfolio Pulse from Aniket Verma

July 29, 2024 | 1:37 am

LGVN

Longeveron Inc. (NASDAQ:LGVN) announced positive results from its Phase 2a clinical trial of Lomecel-B for mild Alzheimer's Disease. The study met its key objectives, supporting a favorable benefit/risk profile. The results were presented at the Alzheimer’s Association International Conference (AAIC) 2024.

Portfolio Pulse from charles@benzinga.com

July 28, 2024 | 10:56 pm

AVXL

Anavex Life Sciences Corp. (NASDAQ:AVXL) announced that its drug blarcamesine significantly slowed clinical decline in early Alzheimer's disease patients in a Phase IIb/III study. The primary cognitive endpoint ADAS-Cog13 showed significant improvement, while the functional endpoint ADCS-ADL trended positive but did not reach significance. The study also showed significant results in secondary endpoints and biomarkers.

Portfolio Pulse from charles@benzinga.com

July 28, 2024 | 10:53 pm

AAPL

CRWD

META

NVDA

RBLX

TXN

WBD

The past week in consumer tech saw significant developments including a global tech outage caused by a flawed update from CrowdStrike Holdings Inc. (CRWD), leading to widespread criticism. Roblox Corporation (RBLX) reported a sharp increase in child exploitation incidents. Apple Inc. (AAPL) and Texas Instruments (TXN) both reported earnings that beat analyst estimates. Nvidia Corp. (NVDA) is developing a new AI chip for the Chinese market and has approved the use of Samsung's HBM3 chips. Meta Platforms Inc. (META) faces scrutiny from the EU over its 'pay or consent' model. Warner Bros. Discovery, Inc. (WBD) announced the acquisition of Player First Games.

Portfolio Pulse from Lekha Gupta

July 28, 2024 | 7:39 pm

EVR

LAZ

Key Wall Street figures, including leaders from Blackstone, Lazard, Evercore ISI, and Goldman Sachs, are endorsing Vice President Kamala Harris's presidential bid despite her past confrontations with the financial sector. This support suggests a potential balance between regulation and economic growth under her administration.

Portfolio Pulse from Bibhu Pattnaik

July 28, 2024 | 6:34 pm

ASTS

BEAM

CLDX

GSHD

VKTX

VSAT

Six mid-cap stocks, including AST SpaceMobile, Goosehead Insurance, ViaSat, Viking Therapeutics, Beam Therapeutics, and Celldex Therapeutics, were the top performers last week. AST SpaceMobile saw a 47.88% increase, Goosehead Insurance rose by 39.86%, ViaSat escalated by 30.78%, Viking Therapeutics grew by 29.86%, Beam Therapeutics increased by 23.93%, and Celldex Therapeutics rose by 19.72%.

Portfolio Pulse from Lekha Gupta

July 28, 2024 | 6:17 pm

DELL

LKQ

MBLY

SMCI

STLA

STM

TER

UPS

VRT

WST

The article highlights the top 12 large-cap stock losers from July 21 to July 27, including Ford, Stellantis, and Dell. Key reasons for the declines include earnings misses, lowered guidance, and broader market selloffs.

Portfolio Pulse from Lekha Gupta

July 28, 2024 | 5:58 pm